Cell lipid metabolism modulators 2-bromopalmitate, D609, monensin, U18666A and probucol shift discoidal HDL formation to the smaller-sized particles: implications for the mechanism of HDL assembly

Phillips, 2013, New insights into the determination of HDL structure by apolipoproteins: Thematic review series: high density lipoprotein structure, function, and metabolism, J. Lipid Res., 54, 2034, 10.1194/jlr.R034025 Liu, 2003, Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high density lipoprotein particles, J. Biol. Chem., 278, 42976, 10.1074/jbc.M308420200 Krimbou, 2005, Biogenesis and speciation of nascent apoA-I-containing particles in various cell lines, J. Lipid Res., 46, 1668, 10.1194/jlr.M500038-JLR200 Hayashi, 2005, Heterogeneity of high density lipoprotein generated by ABCA1 and ABCA7, J. Lipid Res., 46, 1703, 10.1194/jlr.M500092-JLR200 Duong, 2006, Characterization of nascent HDL particles and microparticles formed by ABCA1-mediated efflux of cellular lipids to apoA-I, J. Lipid Res., 47, 832, 10.1194/jlr.M500531-JLR200 Jonas, 1984, A review of plasma apolipoprotein A-I interactions with phosphatidylcholines, Exp. Lung Res., 6, 255, 10.3109/01902148409109252 Swaney, 1980, Properties of lipid•apolipoprotein association products. Complexes of dimyristoyl phosphatidylcholine and human apo A-1, J. Biol. Chem., 255, 877, 10.1016/S0021-9258(19)86114-8 Matz, 1982, Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions, J. Biol. Chem., 257, 4535, 10.1016/S0021-9258(18)34756-2 Zheng, 2001, Stably transfected ABCA1 antisense cell line has decreased ABCA1 mRNA and cAMP-induced cholesterol efflux to apolipoprotein AI and HDL, Biochim. Biophys. Acta, 1534, 121, 10.1016/S1388-1981(01)00183-4 Lyssenko, 2013, Factors controlling nascent high-density lipoprotein particle heterogeneity: ATP-binding cassette transporter A1 activity and cell lipid and apolipoprotein AI availability, FASEB J., 27, 2880, 10.1096/fj.12-216564 Massey, 2008, Cholesterol is a determinant of the structures of discoidal high density lipoproteins formed by the solubilization of phospholipid membranes by apolipoprotein A-I, Biochim. Biophys. Acta, 1781, 245, 10.1016/j.bbalip.2008.03.003 Miyazaki, 2013, Effect of phospholipid composition on discoidal HDL formation, Biochim. Biophys. Acta, 1828, 1340, 10.1016/j.bbamem.2013.01.012 Zorich, 1987, Properties of discoidal complexes of human apolipoprotein A-I with phosphatidylcholines containing various fatty acid chains, Biochim. Biophys. Acta, 919, 181, 10.1016/0005-2760(87)90206-2 Davda, 2013, Profiling targets of the irreversible palmitoylation inhibitor 2-bromopalmitate, ACS Chem. Biol., 8, 1912, 10.1021/cb400380s Singaraja, 2009, Palmitoylation of ATP-binding cassette transporter A1 is essential for its trafficking and function, Circ. Res., 105, 138, 10.1161/CIRCRESAHA.108.193011 Faulkner, 2008, An analysis of the role of a retroendocytosis pathway in ABCA1-mediated cholesterol efflux from macrophages, J. Lipid Res., 49, 1322, 10.1194/jlr.M800048-JLR200 Denis, 2004, Characterization of oligomeric human ATP binding cassette transporter A1. Potential implications for determining the structure of nascent high density lipoprotein particles, J. Biol. Chem., 279, 41529, 10.1074/jbc.M406881200 Oram, 2001, ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol, J. Biol. Chem., 276, 39898, 10.1074/jbc.M106984200 Chamberlain, 2015, The physiology of protein S-acylation, Physiol. Rev., 95, 341, 10.1152/physrev.00032.2014 Blaskovic, 2013, What does S-palmitoylation do to membrane proteins?, FEBS J., 280, 2766, 10.1111/febs.12263 Lund-Katz, 2013, Mechanisms responsible for the compositional heterogeneity of nascent high density lipoprotein, J. Biol. Chem., 288, 23150, 10.1074/jbc.M113.495523 Trompier, 2006, Transition from dimers to higher oligomeric forms occurs during the ATPase cycle of the ABCA1 transporter, J. Biol. Chem., 281, 20283, 10.1074/jbc.M601072200 Lange, 2016, Active membrane cholesterol as a physiological effector, Chem. Phys. Lipids, 199, 74, 10.1016/j.chemphyslip.2016.02.003 Das, 2013, Use of mutant 125I-perfringolysin O to probe transport and organization of cholesterol in membranes of animal cells, Proc. Natl. Acad. Sci. U. S. A., 110, 10580, 10.1073/pnas.1309273110 Radhakrishnan, 2000, Chemical activity of cholesterol in membranes, Biochemistry, 39, 8119, 10.1021/bi0005097 López, 2011, Molecular mechanism of cyclodextrin mediated cholesterol extraction, PLoS Comput. Biol., 7, 10.1371/journal.pcbi.1002020 Brunham, 2006, Variations on a gene: rare and common variants in ABCA1 and their impact on HDL cholesterol levels and atherosclerosis, Annu. Rev. Nutr., 26, 105, 10.1146/annurev.nutr.26.061505.111214 Vaughan, 2009, ABCA1 mutants reveal an interdependency between lipid export function, apoA-I binding activity, and Janus kinase 2 activation, J. Lipid Res., 50, 285, 10.1194/jlr.M800366-JLR200 Adibhatla, 2012, Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literature, Neurochem. Res., 37, 671, 10.1007/s11064-011-0659-z Kallen, 1993, Monensin inhibits synthesis of plasma membrane sphingomyelin by blocking transport of ceramide through the Golgi: evidence for two sites of sphingomyelin synthesis in BHK cells, Biochim. Biophys. Acta, 1166, 305, 10.1016/0005-2760(93)90111-L Cenedella, 2009, Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes, Lipids, 44, 477, 10.1007/s11745-009-3305-7 Ito, 2002, Apolipoprotein-mediated cellular lipid release requires replenishment of sphingomyelin in a phosphatidylcholine-specific phospholipase C-dependent manner, J. Biol. Chem., 277, 44709, 10.1074/jbc.M208379200 Kellner-Weibel, 2003, Cytotoxic cellular cholesterol is selectively removed by apoA-I via ABCA1, Atherosclerosis, 171, 235, 10.1016/j.atherosclerosis.2003.08.024 Mendez, 1995, Monensin and brefeldin A inhibit high density lipoprotein-mediated cholesterol efflux from cholesterol-enriched cells. Implications for intracellular cholesterol transport, J. Biol. Chem., 270, 5891, 10.1074/jbc.270.11.5891 Lu, 2008, ApoA-I facilitates ABCA1 recycle/accumulation to cell surface by inhibiting its intracellular degradation and increases HDL generation, Arterioscler. Thromb. Vasc. Biol., 28, 1820, 10.1161/ATVBAHA.108.169482 Azuma, 2009, Retroendocytosis pathway of ABCA1/apoA-I contributes to HDL formation, Genes Cells, 14, 191, 10.1111/j.1365-2443.2008.01261.x Denis, 2008, ATP-binding cassette A1-mediated lipidation of apolipoprotein A-I occurs at the plasma membrane and not in the endocytic compartments, J. Biol. Chem., 283, 16178, 10.1074/jbc.M709597200 Stubbs, 1984, The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function, Biochim. Biophys. Acta, 779, 89, 10.1016/0304-4157(84)90005-4 Tanaka, 2003, Effects of mutations of ABCA1 in the first extracellular domain on subcellular trafficking and ATP binding/hydrolysis, J. Biol. Chem., 278, 8815, 10.1074/jbc.M206885200 Osawa, 1987, Fractionation and structural assessment of oligosaccharides and glycopeptides by use of immobilized lectins, Annu. Rev. Biochem., 56, 21, 10.1146/annurev.bi.56.070187.000321 Nandi, 2009, ABCA1-mediated cholesterol efflux generates microparticles in addition to HDL through processes governed by membrane rigidity, J. Lipid Res., 50, 456, 10.1194/jlr.M800345-JLR200 Tang, 2009, The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor, J. Biol. Chem., 284, 32336, 10.1074/jbc.M109.047472 Yamashita, 2015, Did we abandon probucol too soon?, Curr. Opin. Lipidol., 26, 304, 10.1097/MOL.0000000000000199 Franceschini, 1989, Mechanisms of HDL reduction after probucol. Changes in HDL subfractions and increased reverse cholesteryl ester transfer, Arteriosclerosis, 9, 462, 10.1161/01.ATV.9.4.462 Favari, 2004, Probucol inhibits ABCA1-mediated cellular lipid efflux, Arterioscler. Thromb. Vasc. Biol., 24, 2345, 10.1161/01.ATV.0000148706.15947.8a Wu, 2004, Probucol inactivates ABCA1 in the plasma membrane with respect to its mediation of apolipoprotein binding and high density lipoprotein assembly and to its proteolytic degradation, J. Biol. Chem., 279, 30168, 10.1074/jbc.M403765200 Chisholm, 2002, ApoA-I secretion from HepG2 cells: evidence for the secretion of both lipid-poor apoA-I and intracellularly assembled nascent HDL, J. Lipid Res., 43, 36, 10.1016/S0022-2275(20)30184-X Gillard, 2009, Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells, Biochim. Biophys. Acta, 1791, 1125, 10.1016/j.bbalip.2009.07.004 Nagao, 2009, Sodium taurocholate-dependent lipid efflux by ABCA1: effects of W590S mutation on lipid translocation and apolipoprotein A-I dissociation, J. Lipid Res., 50, 1165, 10.1194/jlr.M800597-JLR200 Sorci-Thomas, 2012, Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomers, J. Lipid Res., 53, 1890, 10.1194/jlr.M026674 Nagao, 2012, ATP hydrolysis-dependent conformational changes in the extracellular domain of ABCA1 are associated with apoA-I binding, J. Lipid Res., 53, 126, 10.1194/jlr.M019976 Quazi, 2013, Differential phospholipid substrates and directional transport by ATP-binding cassette proteins ABCA1, ABCA7, and ABCA4 and disease-causing mutants, J. Biol. Chem., 288, 34414, 10.1074/jbc.M113.508812 Takahashi, 2006, Purification and ATPase activity of human ABCA1, J. Biol. Chem., 281, 10760, 10.1074/jbc.M513783200 Uehara, 2002, Polyunsaturated fatty acids and acetoacetate downregulate the expression of the ATP-binding cassette transporter A1, Diabetes, 51, 2922, 10.2337/diabetes.51.10.2922 Wang, 2005, Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a phospholipase D2 pathway, J. Biol. Chem., 280, 35896, 10.1074/jbc.M506210200 Markovska, 1990, Effect of probucol on the lipid composition of blood plasma, erythrocyte ghosts and liver membranes in mice, Int. J. Biochem., 22, 1009, 10.1016/0020-711X(90)90208-K Nagata, 2013, ABCA1 dimer-monomer interconversion during HDL generation revealed by single-molecule imaging, Proc. Natl. Acad. Sci. U. S. A., 110, 5034, 10.1073/pnas.1220703110 Segrest, 2015, Surface density-induced pleating of a lipid monolayer drives nascent high-density lipoprotein assembly, Structure, 23, 1214, 10.1016/j.str.2015.05.010 Lin, 2000, Apolipoprotein binding to protruding membrane domains during removal of excess cellular cholesterol, Atherosclerosis, 149, 359, 10.1016/S0021-9150(99)00503-1 Vedhachalam, 2007, Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles, J. Biol. Chem., 282, 25123, 10.1074/jbc.M704590200 Chroni, 2004, Cross-linking and lipid efflux properties of apoA-I mutants suggest direct association between apoA-I helices and ABCA1, Biochemistry, 43, 2126, 10.1021/bi035813p Lyssenko, 2011, A novel compound inhibits reconstituted high-density lipoprotein assembly and blocks nascent high-density lipoprotein biogenesis downstream of apolipoprotein AI binding to ATP-binding cassette transporter A1-expressing cells, Arterioscler. Thromb. Vasc. Biol., 31, 2700, 10.1161/ATVBAHA.111.234906 Gillotte, 1999, Apolipoprotein-mediated plasma membrane microsolubilization. Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid, J. Biol. Chem., 274, 2021, 10.1074/jbc.274.4.2021 Cavigiolio, 2008, The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses, Biochemistry, 47, 4770, 10.1021/bi7023354 Darabi, 2016, Phosphatidylserine in atherosclerosis, Curr. Opin. Lipidol., 27, 414, 10.1097/MOL.0000000000000298 Mendivil, 2016, Novel pathways of apolipoprotein A-I metabolism in high-density lipoprotein of different sizes in humans, Arterioscler. Thromb. Vasc. Biol., 36, 156, 10.1161/ATVBAHA.115.306138